SCHEMBL8303072

SCHEMBL8303072

CC[C@@H](C)N1c2ncccc2NC(=O)c2cccnc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.46
CYP1A2 P05177 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CHRM2 P08172 4/20 0.44
LMNA P02545 3/20 0.43
ALDH1A1 P00352 2/20 0.43
CHRM1 P11229 2/20 0.43
USP2 O75604 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
CYP2D6 P10635 1/20 0.43
CHRM3 P20309 1/20 0.43
GMNN O75496 1/20 0.42
APEX1 P27695 1/20 0.42
POLB P06746 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
MAPK1 P28482 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
PDE3A Q14432 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8302193 1.00 RAB9A (0.46) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL8304745 0.86 CYP1A2 (0.49) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL8300334 0.78 RAB9A (0.50) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL8301869 0.76 CHRM2 (0.48) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL8790717 0.72 RAB9A (0.53) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL9369774 0.72 RAB9A (0.59) RAB9ACYP1A2CHRM2LMNAALDH1A1
SCHEMBL9705864 0.71 RAB9A (0.58) RAB9ACYP1A2CHRM2LMNAALDH1A1
SCHEMBL8790773 0.70 RAB9A (0.53) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL9174480 0.70 RAB9A (0.60) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL9705877 0.70 CYP1A2 (0.53) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP claimed
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP disclosed
EP-0482481-A1 Method for the preparation of 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepines BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1992-04-29 EP disclosed